Immune checkpoint and COPD

Tom Wilkinson (Southampton, United Kingdom)

Source: ERS Lung Science Conference 2017
Number: 30
Disease area: Airway diseases

PDF journal article, handout or slidesSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Tom Wilkinson (Southampton, United Kingdom). Immune checkpoint and COPD. ERS Lung Science Conference 2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Immune checkpoint inhibitors in lung cancer
Source: International Congress 2016 – GR3 Scientific Grand Round: precision medicine
Year: 2016

Immune checkpoints in chronic obstructive pulmonary disease
Source: Eur Respir Rev, 26 (144) 170045; 10.1183/16000617.0045-2017
Year: 2017

Management of pulmonary toxicity associated with immune checkpoint inhibitors
Source: Eur Respir Rev, 28 (154) 190012; 10.1183/16000617.0012-2019
Year: 2019

Immune checkpoint inhibitor-associated interstitial lung diseases: some progress but still many issues
Source: Eur Respir J, 50 (2) 1701319; 10.1183/13993003.01319-2017
Year: 2017

Immune answer in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 310s
Year: 2002

Adaptive immune system in COPD: auto-immunity or bystander?
Source: Annual Congress 2012 - ERS COPD Research Award Ceremony (supported by Boehringer Ingelheim) followed by the Hot Topic "It takes two to tango: innate and adaptive immunity in COPD"
Year: 2012

Pulmonary and systemic cellular immune response network in patients with mild-moderate COPD
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017

Innate immune activation in bronchiectasis
Source: Annual Congress 2004 - Immunology of airway and pulmonary disease
Year: 2004

PTX3 a marker of innate immune responses in the airways of asthmatics and COPD patients
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013

Late Breaking Abstract - B cell adaptive immune profile in emphysema-predominant COPD
Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2019

Targeting the epigenome in asthma and COPD
Source: Annual Congress 2013 –PG6 Epigenetics of asthma and COPD
Year: 2013

Pulmonary senescence in chronic obstructive pulmonary disease is primarily mediated by persistent DNA double strand breaks
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013

Humoral immunity parameters in smoking and non-smoking patients with COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014

Immune system dysregulation in chronic lung disease
Source: Eur Respir J 2011; 38: 500-501
Year: 2011

Activation of the inflammasome pathway during exacerbations of COPD
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011

The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease
Source: International Congress 2014 – Cell biology 2014
Year: 2014

Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer
Source: Eur Respir Rev, 28 (153) 190058; 10.1183/16000617.0058-2019
Year: 2019

LSC 2014 abstract - Targeting of microRNAs can restore innate anti-viral response in asthma
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014